Biohaven Reports Q1 Results
Biohaven 1Q Loss $179.5M >BHVN
Biohaven 1Q Loss $179.5M >BHVN
Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the sto
Independent Director of Biohaven John Childs Buys 3.2% More Shares
Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)
Biohaven(BHVN.US) Director Buys US$999.17K in Common Stock
$Biohaven(BHVN.US)$ Director Bailey Gregory purchased 25,503 shares of common stock on Apr 24, 2024 at an average price of $39.1785 for a total value of $999.17K.Source: Announcement What is statement
Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing
Gregory Bailey, Director, on April 24, 2024, executed a purchase for 25,503 shares in Biohaven (BHVN) for $999,169. Following the Form 4 filing with the SEC, Bailey has control over a total of 1,600,0
Biohaven Is Maintained at Buy by UBS
Biohaven Is Maintained at Buy by UBS
Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO
Biohaven (BHVN) shares rose 6.3% in recent Tuesday trading after the company announced the closing of its underwritten public offering and disclosed Chief Executive Vlad Coric's purchase of company sh
UBS: Maintaining the Biohaven (BHVN.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $59.00 to $60.00.
UBS: Maintaining the Biohaven (BHVN.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $59.00 to $60.00.
UBS Maintains Buy on Biohaven, Raises Price Target to $60
UBS analyst Ashwani Verma maintains Biohaven with a Buy and raises the price target from $59 to $60.
Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)
Biohaven Insider Bought Shares Worth $4,999,991, According to a Recent SEC Filing
Vlad Coric, Director, Chief Executive Officer, on April 22, 2024, executed a purchase for 121,951 shares in Biohaven (BHVN) for $4,999,991. Following the Form 4 filing with the SEC, Coric has control
Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Becton Dickinson (BDX)
Biohaven Shares Are Trading Lower After the Company on Thursday Priced a 5.609 Million Share Offering at $41 per Share.
Biohaven Shares Are Trading Lower After the Company on Thursday Priced a 5.609 Million Share Offering at $41 per Share.
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
Biohaven Ltd. (NYSE: BHVN) today announced the pricing of its underwritten public offering of 5,609,757 of its common shares at a price to the public of $41.00 per share. In addition, Biohaven has granted the underwriters a 30-day option to purchase up to an additional 841,463 common shares at the public offering price, less underwriting discounts, and commissions.
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
Health care stocks were mixed pre-bell Thursday, with the iShares Biotechnology ETF (IBB) down 0.1% and the Health Care Select Sector SPDR Fund (XLV) 0.4% higher. Elevance Health (ELV) stock was up mo
Biohaven Drops 4%, Prices $230M Share Offering
Biohaven Reports Pricing Of Public Offering Of 5.609M Of Its Common Shares At $41 Per Share
The gross proceeds from the offering are expected to be approximately $230 million before deducting underwriting discounts and commissions and offering expenses payable by Biohaven. Biohaven intends t
Biohaven Announces Proposed Underwritten Offering of Shares
No Data